Differences in regional brain metabolism associated with specific formulations of hormone therapy in postmenopausal women at risk for AD

Psychoneuroendocrinology

Volumn 36, Issue 4, 2011, Pages 502-513

  Silverman, Daniel H S ^a   Geist, Cheri L ^a   Kenna, Heather A ^b   Williams, Katherine ^b   Wroolie, Tonita ^b   Powers, Bevin ^b   Brooks, John ^c   Rasgon, Natalie L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AD; Estrogen formulations; Hormone therapy; PET; Postmenopausal; Verbal memory

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; FLUORODEOXYGLUCOSE F 18; PROGESTERONE;

ADULT; AGED; ALZHEIMER DISEASE; ANTERIOR CINGULATE; ARTICLE; BRAIN METABOLISM; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; FRONTAL CORTEX; HUMAN; INFERIOR FRONTAL GYRUS; NEUROPROTECTION; NEUROPSYCHOLOGICAL TEST; PARAHIPPOCAMPAL GYRUS; POSITRON EMISSION TOMOGRAPHY; POSTMENOPAUSE; PRIORITY JOURNAL; SUPERIOR FRONTAL GYRUS; SUPERIOR TEMPORAL GYRUS; TEMPORAL CORTEX; TEMPORAL LOBE; VERBAL MEMORY; WERNICKE AREA;

AGED; ALZHEIMER DISEASE; BRAIN; BRAIN CHEMISTRY; CHEMISTRY, PHARMACEUTICAL; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ORGAN SPECIFICITY; POSITRON-EMISSION TOMOGRAPHY; POSTMENOPAUSE; PROGESTERONE; RISK FACTORS;

EID: 79952040495     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2010.08.002     Document Type: Article

References (85)

1. Archer J.S. Relationship between estrogen, serotonin, and depression. Menopause 1999, 6(1):71-78.
2. Arnold A.P., Breedlove S.M. Organizational and activational effects of sex steroids on brain and behavior: a reanalysis. Horm. Behav. 1985, 19(4):469-498.
3. Barrett-Connor E., Laughlin G.A. Endogenous and exogenous estrogen, cognitive function, and dementia in postmenopausal women: evidence from epidemiologic studies and clinical trials. Semin. Reprod. Med. 2009, 27(3):275-282.
4. Bartholomeusz C.F., Wesnes K.A., Kulkarni J., Vitetta L., Croft R.J., Nathan P.J. Estradiol treatment and its interaction with the cholinergic system: effects on cognitive function in healthy young women. Horm. Behav. 2008, 54(5):684-693.
5. Bishop J., Simpkins J.W. Estradiol enhances brain glucose uptake in ovariectomized rats. Brain. Res. Bull. 1995, 36(3):315-320.
6. Bora S.H., Liu Z., Kecojevic A., Merchenthaler I., Koliatsos V.E. Direct, complex effects of estrogens on basal forebrain cholinergic neurons. Exp. Neurol. 2005, 194(2):506-522.
7. Brinton R.D. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Ann. N. Y. Acad. Sci. 2005, 1052:57-74.
8. Dominguez R., Jalali C., de Lacalle S. Morphological effects of estrogen on cholinergic neurons in vitro involves activation of extracellular signal-regulated kinases. J. Neurosci. 2004, 24(4):982-990.
9. Eberling J.L., Reed B.R., Coleman J.E., Jagust W.J. Effect of estrogen on cerebral glucose metabolism in postmenopausal women. Neurology 2000, 55(6):875-877.
10. Eberling J.L., Wu C., Tong-Turnbeaugh R., Jagust W.J. Estrogen- and tamoxifen-associated effects on brain structure and function. Neuroimage 2004, 21(1):364-371.
11. Espeland M.A., Rapp S.R., Shumaker S.A., Brunner R., Manson J.E., Sherwin B.B., Hsia J., Margolis K.L., Hogan P.E., Wallace R., Dailey M., Freeman R., Hays J. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004, 291(24):2959-2968.
12. Fahn, S., Elton, R.L., 1987. The UPRDS development committee. In: Fahn, S., Marsden, C.D., Calne, D., Goldstein, M. (Eds.), Recent Developments in Parkinson's Disease. Macmillan, New Jersey, 2, pp. 153-163.
13. Fletcher P.C., Shallice T., Frith C.D., Frackowiak R.S., Dolan R.J. The functional roles of prefrontal cortex in episodic memory. II. Retrieval. Brain 1998, 121(PT7):1249-1256.
14. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state" A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12(3):189-198.
15. Friston K., Ashburner J., Frith C., et al. Spatial registration and normalization of images. Hum. Brain Mapp. 1995, 2:165-189.
16. Friston K., Holmes A., Worsley K., et al. Statistical parametric maps in functional imaging: a general linear approach. Hum. Brain Mapp. 1995, 2:189-210.
17. Frye C.A., Duffy C.K., Walf A.A. Estrogens and progestins enhance spatial learning of intact and ovariectomized rats in the object placement task. Neurobiol. Learn. Mem. 2007, 88(2):208-216.
18. Gabrieli J.D., Brewer J.B., Desmond J.E., Glover G.H. Separate neural bases of two fundamental memory processes in the human medial temporal lobe. Science 1997, 276(5310):264-266.
19. Genazzani A.R., Pluchino N., Luisi S., Luisi M. Estrogen, cognition and female ageing. Hum. Reprod. Update 2007, 13(2):175-187.
20. Gleason C., Schmitz T., Hess T., et al. Hormone effects on fMRI and cognitive measures of encoding: importance of hormone preparation. Neurology 2006, 67(11):2039-2041.
21. Halbreich U., Rojansky N., Palter S., Tworek H., Hissin P., Wang K. Estrogen augments serotonergic activity in postmenopausal women. Biol. Psychiatr. 1995, 37(7):434-441.
22. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatr. 1960, 23:56-62.
23. Hänninen T., Hallikainen M., Koivisto K., Helkala E.L., Reinikainen K.J., Soininen H., Mykkänen L., Laakso M., Pyörälä K., Riekkinen P.J. A follow-up study of age-associated memory impairment: neuropsychological predictors of dementia. J. Am. Geriatr. Soc. 1995, 43(9):1007-1015.
24. Henderson V.W., Benke K.S., Green R.C., Cupples L.A., Farrer L.A. MIRAGE Study Group. Postmenopausal hormone therapy and Alzheimer's disease risk: interaction with age. Am. J. Psychiatr. 2005, 162(4):683-690.
25. Ibáñez V., Pietrini P., Alexander G.E., Furey M.L., Teichberg D., Rajapakse J.C., Rapoport S.I., Schapiro M.B., Horwitz B. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 1998, 50(6):1585-1593.
26. Joffe H., Hall J., Gruber S., et al. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause 2006, 13(3):411-422.
27. Kendall D.A., Stancel G.M., Enna S.J. Imipramine: effect of ovarian steroids on modifications in serotonin receptor binding. Science 1981, 211(4487):1183-1185.
28. Kompoliti K., Chu Y., Polish A., Roberts J., McKay H., Mufson E.J., Leurgans S., Morrison J.H., Kordower J.H. Effects of estrogen replacement therapy on cholinergic basal forebrain neurons and cortical cholinergic innervation in young and aged ovariectomized rhesus monkeys. J. Comp. Neurol. 2004, 472(2):193-207.
29. Lasiuk G.C., Hegadoren K.M. The effect of estradiol on central serotonergic systems and its relationship to mood in women. Biol. Res. Nurs. 2007, 9(2):147-160.
30. Luine V.N. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp. Neurol. 1985, 89(2):484-490.
31. Maki P.M., Gast M.J., Vieweg A.J., Burriss S.W., Yaffe K. Hormone therapy in menopausal women with cognitive complaints: a randomized double-blind trial. Neurology 2007, 69(13):1322-1330.
32. Maki P.M., Resnick S.M. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol. Aging. 2000, 21(2):373-383.
33. Maki P.M., Resnick S.M. Effects of estrogen on patterns of brain activity at rest and during cognitive activity: a review of neuroimaging studies. Neuroimage 2001, 14(4):789-801.
34. Maki P.M. Hormone therapy and cognitive function: is there a critical period for benefit?. Neuroscience 2006, 138(3):1027-1030.
35. Martin A., Fedio P. Word production and comprehension in Alzheimer's disease: the breakdown of semantic knowledge. Brain Lang. 1983, 19(1):124-141.
36. McEwen B.S., Coirini H., Danielsson A., Frankfurt M., Gould E., Mendelson S., Schumacher M., Segarra A., Woolley C. Steroid and thyroid hormones modulate a changing brain. J. Steroid Biochem. Mol. Biol. 1991, 40(1-3):1-14.
37. McEwen B.S. Neural estrogen receptors in the life cycle of the albino rat. Exp. Brain Res. 1981, Suppl. 3:61-79.
38. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34(7):939-944.
39. Meusburger S.M., Keast J.R. Testosterone and nerve growth factor have distinct but interacting effects on structure and neurotransmitter expression of adult pelvic ganglion cells in vitro. Neuroscience 2001, 108(2):331-340.
40. Miller V.M., Black D.M., Brinton E.A., Budoff M.J., Cedars M.I., Hodis H.N., Lobo R.A., Manson J.E., Merriam G.R., Naftolin F., Santoro N., Taylor H.S., Harman S.M. Using basic science to design a clinical trial: Baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). J. Cardiovasc. Transl. Res. 2009, 2(3):228-239.
41. Moses E.L., Drevets W.C., Smith G., Mathis C.A., Kalro B.N., Butters M.A., Leondires M.P., Greer P.J., Lopresti B., Loucks T.L., Berga S.L. Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study. Biol. Psychiatr. 2000, 48(8):854-860.
42. Namba H., Sokoloff L. Acute administration of high doses of estrogen increases glucose utilization throughout brain. Brain Res. 1984, 291(2):391-394.
43. Nappi R.E., Sinforiani E., Mauri M., Bono G., Polatti F., Nappi G. Memory functioning at menopause: impact of age in ovariectomized women. Gynecol. Obstet. Invest. 1999, 47(1):29-36.
44. Nehlig A., Porrino L.G., Crane A.M., Sokoloff L. Local cerebral glucose utilization in normal female rats: variations during the estrous cycle and comparison with males. J. Cereb. Blood Flow Metab. 1985, 5(3):393-400.
45. Ottowitz W.E., Siedlecki K.L., Lindquist M.A., Dougherty D.D., Fischman A.J., Hall J.E. Evaluation of prefrontal-hippocampal effective connectivity following 24h of estrogen infusion: an FDG-PET study. Psychoneuroendocrinology 2008, 33(10):1419-1425.
46. Persad C.C., Zubieta J.K., Love T., Wang H., Tkaczyk A., Smith Y.R. Enhanced neuroactivation during verbal memory processing in postmenopausal women receiving short-term hormone therapy. Menopause 2009, 92(1):197-204.
47. Phillips S.M., Sherwin B.B. Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 1992, 17(5):485-495.
48. Ping S.E., Trieu J., Wlodek M.E., Barrett G.L. Effects of estrogen on basal forebrain cholinergic neurons and spatial learning. J. Neurosci. Res. 2008, 86(7):1588-1598.
49. Polkowski K., Mazurek A.P. Biological properties of genistein. A review of in vitro and in vivo data. Acta. Pol. Pharm. 2000, 57(2):135-155.
50. Rapp S.R., Espeland M.A., Shumaker S.A., Henderson V.W., Brunner R.L., Manson J.E., Gass M.L., Stefanick M.L., Lane D.S., Hays J., Johnson K.C., Coker L.H., Dailey M., Bowen D. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: The Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003, 289(20):2663-2672.
51. Rasgon N.L., Geist C.L., Kenna H., Powers B., Wroolie T.E., Silverman D.H. Decline of inferior parietal brain metabolism in postmenopausal women who discontinue hormone therapy. J. Nucl. Med. Meeting Abstracts 2008, 49:226.
52. Rasgon N.L., Kenna H.A., Geist C., Small G., Silverman D. Cerebral metabolic patterns in untreated postmenopausal women with major depressive disorder. Psychiatr. Res. 2008, 164(1):77-80.
53. Rasgon N.L., Silverman D., Siddarth P., Miller K., Ercoli L.M., Elman S., Lavretsky H., Huang S.C., Phelps M.E., Small G.W. Estrogen use and brain metabolic change in postmenopausal women. Neurobiol. Aging 2005, 26(2):229-235.
54. Rasgon N.L., Small G.W., Siddarth P., Miller K., Ercoli L.M., Bookheimer S.Y., Lavretsky H., Huang S.C., Barrio J.R., Phelps M.E. Estrogen use and brain metabolic change in older adults: A preliminary report. Psychiatr. Res. 2001, 107(1):11-18.
55. Reiman E.M., Caselli R.J., Yun L.S., Chen K., Bandy D., Minoshima S., Thibodeau S.N., Osborne D. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N. Engl. J. Med. 1996, 334(12):752-758.
56. Resnick S., Maki P., Golski S., Kraut M., Zonderman A. Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm. Behav. 1998, 34(2):171-182.
57. Resnick S.M., Espeland M.A., An Y., Maki P.M., Coker L.H., Jackson R., Stefanick M.L., Wallace R., Rapp S.R. Women's Health Initiative Study of Cognitive Aging Investigators. Effects of conjugated equine estrogens on cognition and affect in postmenopausal women with prior hysterectomy. J Clin. Endocrinol. Metab. 2009, 94(11):4152-4161.
58. Resnick S.M., Espeland M.A., Jaramillo S.A., Hirsch C., Stefanick M.L., Murray A.M., Ockene J., Davatzikos C. Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI study. Neurology 2009, 72(2):135-142.
59. Resnick S.M., Maki P.M., Rapp S.R., Espeland M.A., Brunner R., Coker L.H., Granek I.A., Hogan P., Ockene J.K., Shumaker S.A. Women's health initiative study of cognitive aging investigators. Effects of combination estrogen plus progestin hormone treatment on cognition and affect. J. Clin. Endocrinol. Metab. 2006, 91(5):1802-1810.
60. Rocca W.A., Bower J.H., Maraganore D.M., Ahlskog J.E., Grossardt B.R., de Andrade M., Melton L.J. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007, 69(11):1074-1083.
61. Roy E.J., Buyer D.R., Licari V.A. Estradiol in the striatum: effects on behavior and dopamine receptors but no evidence for membrane steroid receptors. Brain Res. Bull. 1990, 25(2):221-227.
62. Rubinow D.R., Schmidt P.J., Roca C.A. Estogen-serotonin interactions: implications for affective regulation. Biol. Psychiatr. 1998, 44(9):839-850.
63. Sar M., Stumpf W.E. Central noradrenergic neurons concentrate 3H-oestradiol. Nature 1981, 289(5797):500-502.
64. Shallice T., Fletcher P., Frith C.D., Grasby P., Frackowiak R.S., Dolan R.J. Brain regions associated with acquisition and retrieval of verbal episodic memory. Nature 1994, 368(6472):633-635.
65. Shaywitz S., Shaywitz B., Pugh K., et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 1999, 281(13):1197-1202.
66. Shumaker S.A., Legault C., Kuller L., Rapp S.R., Thal L., Lane D.S., Fillit H., Stefanisk M.L., Hendrix S.L., Lewis C.E., Masaki K., Coker L.H. Women's Health Initiative Memory Study. Conjugated equine estrogens and incidence of probably dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004, 291(24):2947-2958.
67. Shumaker S.A., Legault C., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L., Jones B.N., Assaf A.R., Jackson R.D., Morley Kotchen J., Wassertheil-Smoller S., Wactawski-Wende J. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003, 289(20):2651-2662.
68. Silverman D.H., Dy C.J., Castellon S.A., Lai J., Pio B.S., Abraham L., Waddell K., Petersen L., Phelps M.E., Ganz P.A. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy. Breast Cancer Res. Treat. 2007, 103(3):303-311.
69. Singh M., Meyer E.M., Millard W.J., Simkins J.W. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res. 1994, 644(2):305-312.
70. Small G.W., Kuhl D.E., Riege W.H., Fujikawa D.G., Ashford J.W., Metter E.J., Mazziotta J.C. Cerebral glucose metabolic patterns in Alzheimer's disease. Effect of gender and age at dementia onset. Arch. Gen. Psychiatr. 1989, 46(6):527-532.
71. Small G.W., La Rue A., Komo S., Kaplan A., Mandelkern M.A. Predictors of cognitive change in middle-aged and older adults with memory loss. Am. J. Psychiatr. 1995, 152(12):1757-1764.
72. Smith G.S., de Leon M.J., George A.E., Kluger A., Volkow N.D., McRae T., Golomb J., Ferris S.H., Reisberg B., Ciaravino J., et al. Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications. Arch. Neurol. 1992, 49(11):1142-1150.
73. Smith Y., Love T., Persad C., Tkaczyk A., Nichols T., Zubieta J. Impact of combined estradiol and norethindrone therapy on visuospatial working memory assessed by functional magnetic resonance imaging. J. Clin. Endocrinol. Metab. 2006, 91(11):4476-4481.
74. Smith Y.R., Minoshima S., Kuhl D.E., Zubieta J.K. Effects of long-term hormone therapy on cholinergic synaptic concentrations in healthy postmenopausal women. J. Clin. Endocrinol. Metab. 2001, 86(2):679-684.
75. Squire L.R., Ojemann J.G., Miezin F.M., Petersen S.E., Videen T.O., Raichle M.E. Activation of the hippocampus in normal humans: a function anatomical study of memory. Proc. Natl. Acad. Sci. U. S. A. 1992, 89(5):1837-1841.
76. Stern C.D., Corkin S., Gonzalez R.G., Guimaraes A.R., Baker J.R., Jennings P.J., Carr C.A., Sugiura R.M., Vedantham V., Rosen B.R. The hippocampal formation participates in novel picture encoding: evidence from functional magnetic resonance imaging. Proc. Natl. Acad. Sci. U. S. A. 1996, 93(16):8660-8665.
77. Tai Y.C., Lin K.P., Hoh C.K., Huang S.C., Hoffman E.J. Utilization of 3-D elastic transformation in registration of chest X-ray CT and whole body PET. IEEE Trans. Nucl. Sci. 1997, 44:1606-1612.
78. Toran-Allerand C.D. Novel sites and mechanisms of oestrogen action in the brain. Novartis Fond. Symp. 2000, 230:56-69. discussion 69-73.
79. Tulving E., Markowitsch H.J., Craik F.E., Habib R., Houle S. Novelty and familiarity activations in PET studies of memory encoding and retrieval. Cereb. Cortex 1996, 6(1):71-79.
80. Ungar S., Makman M.H., Morris S.A., Etgen A.M. Estrogen uncouples beta-adrenergic receptor from the stimulatory guanine nucleotide-binding protein in female rat hypothyalamus. Endocrinology 1993, 133(6):2818-2826.
81. Verghese J., Kuslansky G., Katz M.J., Sliwinski M., Crystal H.A., Bushke H., Lipton R.B. Cognitive performance in surgically menopausal women on estrogen. Neurology 2000, 55(6):872-874.
82. Vincent A., Fitzpatrick L.A. Soy isoflavones: are they useful in menopause. Mayo Clin. Proc. 2000, 75(11):1174-1184.
83. Wang G., Drake C.T., Rozenblit M., Zhou P., Alves S.E., Herrick S.P., Hayashi S., Warrier S., Iadecola C., Milner T.A. Evidence that estrogen directly and indirectly modulates C1 adrenergic bulbospinal neurons in the rostral ventrolateral medulla. Brain Res. 2006, 1094(1):163-178.
84. Wiggs C.L., Weisberg J., Martin A. Neural correlates of semantic and episodic memory retrieval. Neuropsychologia 1999, 37(1):103-118.
85. Woolley C.S., Gould E., Frankfurt M., McEwen B.S. Naturally occurring fluctuation in dendritic spine density on adult hippocampal pyramidal neurons. J. Neurosci. 1990, 10(12):4035-4039.